TFF Pharmaceuticals (TFFP) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free TFFP Stock Alerts $3.05 +0.04 (+1.33%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTFF Pharmaceuticals (TFFP) Price Target Decreased by 28.99% to 24.99msn.com - April 17 at 11:27 PMTFF Pharmaceuticals Reports Addl. Positive Phase 2 Data For Tacrolimus Inhalation Powdermarkets.businessinsider.com - April 15 at 9:43 AMTFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessionsglobenewswire.com - April 15 at 7:00 AMTFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - April 1 at 10:13 AMTFF Pharmaceuticals reports positive phase 2 trial resultsinvesting.com - March 29 at 11:52 PMTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 29 at 8:50 AMTFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 28 at 11:31 PMTFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 28 at 4:05 PMTFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programsglobenewswire.com - March 27 at 4:01 PMTFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meetingglobenewswire.com - March 25 at 9:01 AMTFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesglobenewswire.com - March 22 at 3:11 PMTFF Pharmaceuticals, Inc. (TFFP)finance.yahoo.com - March 21 at 9:12 PMmarketbeat.com - March 20 at 12:04 PMTFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesglobenewswire.com - March 20 at 12:00 PMTFF Pharmaceuticals Announces Update on Clinical Programsglobenewswire.com - March 20 at 9:03 AMTFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024globenewswire.com - March 14 at 4:47 PMTff Pharmaceuticals Inc (TFFP)uk.investing.com - March 12 at 6:49 PMmarketbeat.com - February 29 at 9:39 AMTFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conferencefinance.yahoo.com - January 24 at 10:43 AMTFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meetingfinance.yahoo.com - January 9 at 10:39 AMTFF Pharmaceuticals Inc Ordinary Sharesmorningstar.com - January 5 at 1:08 PMPositive Phase II Results Bolster Buy Rating for TFF Pharmaceuticals with Raised Price Targetmarkets.businessinsider.com - December 21 at 8:22 AMTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TACfinanznachrichten.de - December 19 at 8:56 AMTFF Pharma Reveals Positive Initial Data From Ongoing Phase 2 Trials Of TFF VORI And TFF TACmarkets.businessinsider.com - December 19 at 8:56 AMTFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TACfinance.yahoo.com - December 19 at 8:56 AMmarketbeat.com - December 19 at 6:01 AMTFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TACfinance.yahoo.com - December 18 at 5:44 PMTFF Declares Reverse Stock Split For 1 Post-split Share For Every 25 Pre-split Sharesmarkets.businessinsider.com - December 15 at 4:02 PMTFF Pharmaceuticals Announces Reverse Stock Splitfinance.yahoo.com - December 15 at 10:39 AMTFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directorsfinance.yahoo.com - November 30 at 9:05 AMTFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023finance.yahoo.com - November 27 at 8:51 AMTFF Pharmaceuticals Inc Ordinary Shares TFFPmorningstar.com - November 23 at 1:33 PMTFF Pharmaceuticals files for $100M mixed shelfmsn.com - November 21 at 11:50 PMBuy Rating Reaffirmed for TFF Pharmaceuticals: Promising Clinical Trials and Sufficient Funding Forecastedmarkets.businessinsider.com - November 21 at 11:50 PMTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 17 at 8:24 AMTFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 16 at 9:31 AMTFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 14 at 8:30 PMTFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film Freezingfinance.yahoo.com - November 8 at 8:18 PMTFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023finance.yahoo.com - November 7 at 6:51 PMTFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccinesfinance.yahoo.com - October 2 at 6:16 PMTFF Pharmaceuticals to Participate in Upcoming Investor Conferencesfinance.yahoo.com - September 28 at 8:23 PMTFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023finance.yahoo.com - August 23 at 10:01 AM10% Owner At This Health Care Company Sells $94K of Stockbenzinga.com - August 18 at 2:03 PMCEO, Interim President & Vice Chairman of the Board of TFF Pharmaceuticals Picks Up 280% More Stockfinance.yahoo.com - August 18 at 6:46 AMTFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Optionfinance.yahoo.com - August 17 at 8:46 PMTFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 17 at 9:55 AMTFF Pharmaceuticals (TFFP) Receives a Buy from JonesTradingmarkets.businessinsider.com - August 16 at 6:50 PMQ2 2023 TFF Pharmaceuticals Inc Earnings Callfinance.yahoo.com - August 16 at 7:17 AMTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - August 15 at 9:53 AMTFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 15 at 9:53 AM Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). TFFP Media Mentions By Week TFFP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TFFP News Sentiment▼0.000.40▲Average Medical News Sentiment TFFP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TFFP Articles This Week▼11▲TFFP Articles Average Week Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Biofrontera News Today ASLAN Pharmaceuticals News Today Bionomics News Today Lixte Biotechnology News Today Chemomab Therapeutics News Today Pasithea Therapeutics News Today Kineta News Today Universe Pharmaceuticals News Today eFFECTOR Therapeutics News Today Can-Fite BioPharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TFFP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
